abrdn Investment Management’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q2 | $19.6M | Buy |
151,725
+10,356
| +7% | +$1.33M | 0.07% | 150 |
|
|
2017
Q1 | $15.5M | Sell |
141,369
-145,857
| -51% | -$15.9M | 0.05% | 150 |
|
|
2016
Q4 | $21.2M | Sell |
287,226
-268,427
| -48% | -$19.8M | 0.07% | 140 |
|
|
2016
Q3 | $48.5M | Sell |
555,653
-12,704
| -2% | -$1.11M | 0.2% | 113 |
|
|
2016
Q2 | $48.9M | Sell |
568,357
-209,271
| -27% | -$18M | 0.22% | 98 |
|
|
2016
Q1 | $61.8M | Sell |
777,628
-5,347
| -0.7% | -$425K | 0.28% | 91 |
|
|
2015
Q4 | $98.5M | Buy |
+782,975
| New | +$98.5M | 0.42% | 75 |
|
|
2015
Q1 | – | Sell |
-4,171
| Closed | -$496K | – | 421 |
|
|
2014
Q4 | $496K | Sell |
4,171
-5,782
| -58% | -$688K | ﹤0.01% | 339 |
|
|
2014
Q3 | $1.12M | Sell |
9,953
-583,386
| -98% | -$65.5M | ﹤0.01% | 280 |
|
|
2014
Q2 | $56.2M | Buy |
593,339
+24,727
| +4% | +$2.34M | 0.25% | 108 |
|
|
2014
Q1 | $40.2M | Buy |
568,612
+486,236
| +590% | +$34.4M | 0.19% | 112 |
|
|
2013
Q4 | $6.12M | Sell |
82,376
-8,936
| -10% | -$664K | 0.03% | 175 |
|
|
2013
Q3 | $6.92M | Buy |
91,312
+11,806
| +15% | +$895K | 0.04% | 151 |
|
|
2013
Q2 | $6.36M | Buy |
+79,506
| New | +$6.36M | 0.04% | 153 |
|